Twin Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.23M | Buy |
19,426
+447
| +2% | +$99.2K | 0.54% | 37 |
|
|
2025
Q4 | $4.34M | Sell |
18,979
-4,393
| -19% | -$1M | 0.54% | 37 |
|
|
2025
Q3 | $5.41M | Sell |
23,372
-17,033
| -42% | -$3.47M | 0.68% | 24 |
|
|
2025
Q2 | $7.5M | Buy |
40,405
+1,359
| +3% | +$253K | 0.8% | 22 |
|
|
2025
Q1 | $8.18M | Sell |
39,046
-806
| -2% | -$157K | 0.95% | 17 |
|
|
2024
Q4 | $7.08M | Buy |
39,852
+3,214
| +9% | +$591K | 0.78% | 20 |
|
|
2024
Q3 | $7.24M | Sell |
36,638
-402
| -1% | -$75K | 0.82% | 17 |
|
|
2024
Q2 | $6.35M | Buy |
37,040
+509
| +1% | +$84.3K | 0.75% | 21 |
|
|
2024
Q1 | $6.65M | Sell |
36,531
-1,650
| -4% | -$284K | 0.82% | 18 |
|
|
2023
Q4 | $5.92M | Buy |
38,181
+1,417
| +4% | +$207K | 0.78% | 21 |
|
|
2023
Q3 | $5.48M | Buy |
36,764
+11,052
| +43% | +$1.62M | 0.79% | 20 |
|
|
2023
Q2 | $3.46M | Buy |
25,712
+3,858
| +18% | +$566K | 0.45% | 56 |
|
|
2023
Q1 | $3.48M | Sell |
21,854
-3,972
| -15% | -$607K | 0.48% | 54 |
|
|
2022
Q4 | $4.17M | Buy |
25,826
+357
| +1% | +$54.7K | 0.54% | 46 |
|
|
2022
Q3 | $3.42M | Sell |
25,469
-25
| -0.1% | -$3.59K | 0.46% | 57 |
|
|
2022
Q2 | $3.9M | Buy |
25,494
+100
| +0.4% | +$15.3K | 0.5% | 52 |
|
|
2022
Q1 | $4.12M | Sell |
25,394
-80
| -0.3% | -$11.6K | 0.44% | 64 |
|
|
2021
Q4 | $3.45M | Sell |
25,474
-2,270
| -8% | -$268K | 0.35% | 95 |
|
|
2021
Q3 | $2.99M | Sell |
27,744
-4,700
| -14% | -$537K | 0.31% | 107 |
|
|
2021
Q2 | $3.65M | Buy |
32,444
+929
| +3% | +$105K | 0.34% | 98 |
|
|
2021
Q1 | $3.41M | Sell |
31,515
-6,830
| -18% | -$731K | 0.34% | 91 |
|
|
2020
Q4 | $4.11M | Sell |
38,345
-12,872
| -25% | -$1.24M | 0.37% | 81 |
|
|
2020
Q3 | $4.49M | Sell |
51,217
-2,771
| -5% | -$261K | 0.41% | 73 |
|
|
2020
Q2 | $5.3M | Buy |
53,988
+11,439
| +27% | +$1.01M | 0.51% | 50 |
|
|
2020
Q1 | $3.24M | Sell |
42,549
-670
| -2% | -$57.1K | 0.35% | 88 |
|
|
2019
Q4 | $3.83M | Sell |
43,219
-20,470
| -32% | -$1.7M | 0.32% | 103 |
|
|
2019
Q3 | $4.82M | Sell |
63,689
-6,206
| -9% | -$425K | 0.35% | 99 |
|
|
2019
Q2 | $5.08M | Sell |
69,895
-44,825
| -39% | -$3.52M | 0.35% | 104 |
|
|
2019
Q1 | $9.24M | Buy |
114,720
+160
| +0.1% | +$13.1K | 0.46% | 65 |
|
|
2018
Q4 | $10.6M | Sell |
114,560
-5,201
| -4% | -$457K | 0.6% | 44 |
|
|
2018
Q3 | $11.3M | Buy |
119,761
+7,889
| +7% | +$748K | 0.52% | 54 |
|
|
2018
Q2 | $10.4M | Buy |
111,872
+19,222
| +21% | +$1.88M | 0.52% | 53 |
|
|
2018
Q1 | $8.77M | Buy |
+92,650
| New | +$10.2M | 0.45% | 66 |
|
|
2017
Q3 | – | Sell |
-13,168
| Closed | -$955K | – | 326 |
|
|
2017
Q2 | $955K | Buy |
+13,168
| New | +$885K | 0.06% | 277 |
|
|
2016
Q4 | – | Sell |
-4,990
| Closed | -$315K | – | 325 |
|
|
2016
Q3 | $315K | Sell |
4,990
-2,000
| -29% | -$129K | 0.02% | 322 |
|
|
2016
Q2 | $433K | Sell |
6,990
-500
| -7% | -$30.5K | 0.03% | 329 |
|
|
2016
Q1 | $428K | Hold |
7,490
| – | – | 0.03% | 256 |
|
|
2015
Q4 | $444K | Sell |
7,490
-48,000
| -87% | -$2.76M | 0.04% | 251 |
|
|
2015
Q3 | $3.02M | Sell |
55,490
-50,030
| -47% | -$3.26M | 0.29% | 108 |
|
|
2015
Q2 | $7.09M | Buy |
105,520
+17,130
| +19% | +$1.12M | 0.64% | 42 |
|
|
2015
Q1 | $5.17M | Buy |
88,390
+11,420
| +15% | +$690K | 0.45% | 66 |
|
|
2014
Q4 | $5.04M | Buy |
76,970
+1,520
| +2% | +$95.8K | 0.48% | 60 |
|
|
2014
Q3 | $4.36M | Sell |
75,450
-6,270
| -8% | -$348K | 0.44% | 68 |
|
|
2014
Q2 | $4.61M | Buy |
81,720
+37,670
| +86% | +$1.98M | 0.46% | 59 |
|
|
2014
Q1 | $2.26M | Sell |
44,050
-15,150
| -26% | -$766K | 0.24% | 137 |
|
|
2013
Q4 | $3.13M | Sell |
59,200
-28,420
| -32% | -$1.4M | 0.33% | 96 |
|
|
2013
Q3 | $3.92M | Sell |
87,620
-7,580
| -8% | -$336K | 0.42% | 63 |
|
|
2013
Q2 | $3.94M | Buy |
+95,200
| New | +$4.16M | 0.42% | 56 |
|
Other funds holding ABBV
VCM
VPM
Twin Capital Management's ABBV Position: Q1 2026 in Review
Twin Capital Management increased its AbbVie (ABBV) stake by 2.4% in Q1 2026, buying an estimated $99.2K and bringing the position to 19,426 shares worth $4.23M. The position accounts for 0.54% of the portfolio, ranked #37.
Twin Capital Management first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $11.3M in Q3 2018. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Twin Capital Management held 19,426 shares of AbbVie worth $4.23M as of Q1 2026.
- Twin Capital Management bought 447 AbbVie shares in Q1 2026, an estimated $99.2K.
- AbbVie made up 0.54% of Twin Capital Management's portfolio in Q1 2026, its #37 holding.
- Twin Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Twin Capital Management's AbbVie position peaked at $11.3M in Q3 2018.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.